Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
24 March 2023 - 10:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of March 2023
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Celyad Oncology SA
On March 24, 2023, Celyad Oncology SA (the Company) issued a press release announcing the appointment of its new Chief Executive
Officer. A copy of the Companys press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information
contained in this Current Report on Form 6-K, including Exhibit 99.1 except for the quotes of Hilde Windels, Georges Rawadi, and Michel Lussier contained in Exhibit 99.1, is hereby incorporated by reference
into the Companys Registration Statements on Forms F-3 (File No. 333-248464) and S-8 (File No. 333-220737).
EXHIBITS
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA |
|
|
|
|
Date: March 24, 2023 |
|
|
|
By: |
|
/s/ Michel Lussier |
|
|
|
|
|
|
Michel Lussier |
|
|
|
|
|
|
Interim Chief Executive Officer |
Celyad (CE) (USOTC:CLYYF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Celyad (CE) (USOTC:CLYYF)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Celyad SA (CE) (OTCMarkets): 0 recent articles
More Celyad Oncology Sa News Articles